When investors look years ahead instead of weeks, the field of viable cryptocurrencies becomes much smaller. Most toke ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

We recap Industry Season 3's major storylines and character arcs to refresh your memory before the Season 4 premiere.

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes AbbVie, Alexandria Real Estate ...

The Red Wings and Canadiens have taken very different paths back to playoff contention, offering lessons for other NHL ...

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

The Zika virus epidemic that began in Brazil in 2015 and quickly spread to other countries caused an unprecedented flood of ...

A plan to bring the popular Shore restaurant back to St. Armands Circle will likely have to overcome the 50% FEMA rule for ...

Highlighting advanced zero-crossing technology, reliability, and large-scale industrial manufacturing capabilities CALIFORNIA, CA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — As global ...

Secretary of State Marco Rubio announces a three-phase U.S. plan for Venezuela, including oil seizures, sanctions enforcement and a political transition ...

The year-end Goldman Sachs target of 7,600 for the S&P 500 has survived the first six days of the year. That, after Tuesday's close SPX, would represent a 9% increase from current levels. In a new ...

As of Wednesday, January 07, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 7.85%, which has investors questioning if this is right time to buy.